M4 receptor antagonists (Pfizer)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameM4 receptor antagonists (Pfizer)
Drug Alias NamePD-0102807PD-102807PT-3763PD-0306456PT-1148 +[7
ClassificationSmall molecules
Mechanisms of ActionMuscarinic acetylcholine receptor M4 antagonists
TargetsMuscarinic acetylcholine receptor M4
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesParke-Davis CorpPfizer Inc
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A